Log in to save to my catalogue

Recommendations for the management of MPS IVA: systematic evidence- and consensus-based guidance

Recommendations for the management of MPS IVA: systematic evidence- and consensus-based guidance

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_07788539a8b74b2fa1444bee0867e560

Recommendations for the management of MPS IVA: systematic evidence- and consensus-based guidance

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Mucopolysaccharidosis (MPS) IVA or Morquio A syndrome is an autosomal recessive lysosomal storage disorder (LSD) caused by deficiency of the N-acetylgalactosamine-6-sulfatase (GALNS) enzyme, which impairs lysosomal degradation of keratan sulphate and chondroitin-6-sulphate. The multiple clinical manifestations of MPS IVA present numerous challenges...

Alternative Titles

Full title

Recommendations for the management of MPS IVA: systematic evidence- and consensus-based guidance

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_07788539a8b74b2fa1444bee0867e560

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_07788539a8b74b2fa1444bee0867e560

Other Identifiers

ISSN

1750-1172

E-ISSN

1750-1172

DOI

10.1186/s13023-019-1074-9

How to access this item